Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Integrating Quality Monitoring into 3D Bioprinting via Light Sheet Microscopy

Project description

Next-gen bioprinted therapies

Patients suffering from organ failure, severe burns or degenerative diseases could soon benefit from high-quality bioprinted tissues, which open new possibilities in regenerative medicine. Current bioprinting systems struggle to guarantee accuracy, often relying on destructive post-print analyses that slow research and hinder clinical translation. Funded by the European Research Council, the visionPRINT project aims to develop a 3D bioprinting platform with integrated optical imaging and light sheet fluorescence microscopy. For the first time, it will be possible to monitor both shape and cell composition during printing. The project’s overall aim is to speed up research and bring safe bioprinted therapies closer to patients in need.

Objective

A critical bottleneck in bioprinting hardware is the lack of integrated quality monitoring features for characterising print accuracy and cellular composition during fabrication. This limitation makes it challenging to develop reproducible and standardised bioprinting protocols, which are essential for GMP-compliant production. The lack of integrated quality monitoring also leads to a reliance on destructive, post-printing analysis methods that are incompatible with clinical translation.

To address this problem, visionPRINT will develop a 3D bioprinting platform with an optical imaging system and complementary use of Light Sheet Fluorescence Microscopy (LSFM). Unlike current bioprinting hardware systems, visionPRINT will provide volumetric quality assessment of bioprinted constructs. visionPRINT will be the first bioprinting system to offer this level of integrated quality control, and this technological differentiation will help facilitate market adoption as the industry progresses toward standardised protocols and clinical applications.

visionPRINT’s integrated data-driven quality monitoring features will transform bioprinting workflows across research, development, and clinical applications. Comprehensive volumetric data logging capturing both construct shape and cell composition will help end users enhance the accuracy and reproducibility of their bioprinting protocols. Furthermore, the technology will make it easier for end-users to standardise protocols and demonstrate GMP-compliant production for regulatory approval. Ultimately, visionPRINT will accelerate the development of safe and functional bioprinted tissues for clinical applications, benefiting patients worldwide.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

UNIVERSITY OF GALWAY
Net EU contribution
€ 150 000,00
Address
UNIVERSITY ROAD
H91 Galway
Ireland
Region
Ireland Northern and Western West
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)